603882 金域医学
午间休市 06-12 11:29:59
资讯
新帖
简况
每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元
证券之星 · 06-07
每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元
金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权
证券之星 · 06-06
金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权
金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%
证券之星 · 06-02
金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%
每周股票复盘：金域医学（603882）回购股份比例达1.01%
证券之星 · 05-31
每周股票复盘：金域医学（603882）回购股份比例达1.01%
金域医学新注册《检测方法精密度评估系统V1.0.5》项目的软件著作权
证券之星 · 05-30
金域医学新注册《检测方法精密度评估系统V1.0.5》项目的软件著作权
金域医学（603882）披露以集中竞价交易方式回购公司股份比例达1%暨回购进展公告，5月28日股价下跌0.34%
证券之星 · 05-28
金域医学（603882）披露以集中竞价交易方式回购公司股份比例达1%暨回购进展公告，5月28日股价下跌0.34%
金域医学新注册《KMLink双向对接平台-客户端系统V1.1.1.0》等4个项目的软件著作权
证券之星 · 05-28
金域医学新注册《KMLink双向对接平台-客户端系统V1.1.1.0》等4个项目的软件著作权
每周股票复盘：金域医学（603882）已回购217.51万股
证券之星 · 05-10
每周股票复盘：金域医学（603882）已回购217.51万股
金域医学新注册《医学实验室质量管理智慧评估系统V1.0》项目的软件著作权
证券之星 · 05-09
金域医学新注册《医学实验室质量管理智慧评估系统V1.0》项目的软件著作权
金域医学（603882）披露关于新增回购专用证券账户的公告，5月6日股价上涨0.7%
证券之星 · 05-06
金域医学（603882）披露关于新增回购专用证券账户的公告，5月6日股价上涨0.7%
金域医学（603882）披露调整2026年回购股份方案资金来源公告，4月29日股价上涨0.77%
证券之星 · 04-29
金域医学（603882）披露调整2026年回购股份方案资金来源公告，4月29日股价上涨0.77%
金域医学（603882）2026年一季报简析：净利润同比增长254%，盈利能力上升
证券之星 · 04-26
金域医学（603882）2026年一季报简析：净利润同比增长254%，盈利能力上升
每周股票复盘：金域医学（603882）2026年Q1净利增254%
证券之星 · 04-26
每周股票复盘：金域医学（603882）2026年Q1净利增254%
金域医学最新公告：第一季度净利润为4279.05万元同比扭亏为盈
证券之星 · 04-24
金域医学最新公告：第一季度净利润为4279.05万元同比扭亏为盈
每周股票复盘：金域医学（603882）拟回购股份，梁耀铭持股16.02%
证券之星 · 04-19
每周股票复盘：金域医学（603882）拟回购股份，梁耀铭持股16.02%
金域医学新注册《知识产权数据智能提取发送工具系统V1.0》项目的软件著作权
证券之星 · 04-15
金域医学新注册《知识产权数据智能提取发送工具系统V1.0》项目的软件著作权
股市必读：金域医学（603882）3月23日收盘跌6.83%，主力净流入340.59万元
证券之星 · 03-24
股市必读：金域医学（603882）3月23日收盘跌6.83%，主力净流入340.59万元
金域医学新注册《医学实验室生物安全智慧系统V3.2.0》项目的软件著作权
证券之星 · 03-24
金域医学新注册《医学实验室生物安全智慧系统V3.2.0》项目的软件著作权
金域医学新注册《金域tNGS宏组学plus加做管理系统V1.0》等3个项目的软件著作权
证券之星 · 03-22
金域医学新注册《金域tNGS宏组学plus加做管理系统V1.0》等3个项目的软件著作权
金域医学新注册《医检项目智慧定价系统（SPP）V2.38》项目的软件著作权
证券之星 · 03-17
金域医学新注册《医检项目智慧定价系统（SPP）V2.38》项目的软件著作权
加载更多
公司概况
公司名称：
广州金域医学检验集团股份有限公司
所属行业：
卫生
上市日期：
2017-09-08
主营业务：
广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学诊断服务、销售诊断产品、健康体检业务、冷链物流服务。公司参与获批国家科技重大专项4项，国家“战略性科技创新合作”重点专项1项。全年发表论文共101篇，其中SCI论文32篇，学术影响力持续提升。
发行价格：
6.93
{"stockData":{"symbol":"603882","market":"SH","secType":"STK","nameCN":"金域医学","latestPrice":25.15,"timestamp":1781234999000,"preClose":23.55,"halted":0,"volume":5452442,"delay":0,"changeRate":0.0679,"floatShares":459999999,"shares":463000000,"eps":-0.2217,"marketStatus":"午间休市","change":1.6,"latestTime":"06-12 11:29:59","open":23.68,"high":25.22,"low":23.56,"amount":134000000,"amplitude":0.0705,"askPrice":25.15,"askSize":1,"bidPrice":25.14,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-0.2217,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781240400000},"marketStatusCode":3,"adr":0,"adjPreClose":23.55,"symbolType":"stock","openAndCloseTimeList":[[1781227800000,1781235000000],[1781240400000,1781247600000]],"highLimit":25.91,"lowLimit":21.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":463258275,"isCdr":false,"pbRate":1.72,"roa":"--","roe":"0.65%","epsLYR":-0.37,"committee":-0.109312,"marketValue":11651000000,"turnoverRate":0.0118,"status":0,"floatMarketCap":11572000000},"requestUrl":"/m/hq/s/603882/","defaultTab":"news","newsList":[{"id":"2641127107","title":"每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127107?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:46","pubTimestamp":1780771574,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，金域医学报收于24.02元，较上周的25.6元下跌6.17%。本周，金域医学6月1日盘中最高价报26.32元。本周关注点公司公告汇总：金域医学已累计回购465.87万股，占总股本1.01%，支付金额12,553.21万元。回购进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0042","BK0236","SG9999001069.SGD","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641314238","title":"金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2641314238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641314238?lang=zh_cn&edition=full","pubTime":"2026-06-06 02:25","pubTimestamp":1780683915,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学（603882）新注册了《智慧检测线性区间分析系统V1.5.7》项目的软件著作权。今年以来金域医学新注册软件著作权33个，较去年同期减少了37.74%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息221条，著作权信息194条；此外企业还拥有行政许可61个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060600000116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","159180","BK0042","BK0284","SG9999001069.SGD","603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914576","title":"金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914576","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640914576?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:05","pubTimestamp":1780394721,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，金域医学报收于25.74元，较前一交易日下跌1.27%，最新总市值为119.24亿元。该股当日开盘26.05元，最高26.25元，最低25.53元，成交额达1.2亿元，换手率为1.01%。广州金域医学检验集团股份有限公司于2026年6月2日发布《关于以集中竞价交易方式回购公司股份的进展公告》。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200035702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","603882","BK0236","BK0284","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639760466","title":"每周股票复盘：金域医学（603882）回购股份比例达1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639760466","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639760466?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:13","pubTimestamp":1780168390,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，金域医学报收于25.6元，较上周的26.14元下跌2.07%。本周关注点公司公告汇总：金域医学已累计回购股份465.87万股，占总股本1.01%。截至2026年5月28日，已累计回购465.87万股，占公司总股本的1.01%，支付金额12,553.21万元，回购最高价为28.79元/股，最低价为25.33元/股。本次回购符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","603882","BK0042","BK0284","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639671727","title":"金域医学新注册《检测方法精密度评估系统V1.0.5》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2639671727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639671727?lang=zh_cn&edition=full","pubTime":"2026-05-30 02:00","pubTimestamp":1780077650,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学（603882）新注册了《检测方法精密度评估系统V1.0.5》项目的软件著作权。今年以来金域医学新注册软件著作权32个，较去年同期减少了39.62%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息221条，著作权信息193条；此外企业还拥有行政许可61个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053000000644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","159180","BK0236","BK0284","BK0042","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638691711","title":"金域医学（603882）披露以集中竞价交易方式回购公司股份比例达1%暨回购进展公告，5月28日股价下跌0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638691711","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638691711?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:33","pubTimestamp":1779978794,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，金域医学报收于26.18元，较前一交易日下跌0.34%，最新总市值为121.28亿元。该股当日开盘26.23元，最高26.27元，最低25.73元，成交额达1.32亿元，换手率为1.1%。近日，广州金域医学检验集团股份有限公司发布《关于以集中竞价交易方式回购公司股份比例达1%暨回购进展公告》。本次回购符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0042","SG9999001069.SGD","603882","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638295680","title":"金域医学新注册《KMLink双向对接平台-客户端系统V1.1.1.0》等4个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2638295680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638295680?lang=zh_cn&edition=full","pubTime":"2026-05-28 02:06","pubTimestamp":1779905180,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了4个项目的软件著作权，包括《KMLink双向对接平台-客户端系统V1.1.1.0》、《基于NGS的HLA动态深度抽提工具软件V1.0》、《金域Kmlink-GZCancer系统V1.0》、《检测下限智能分析系统V1.0.0》等。今年以来金域医学新注册软件著作权31个，较去年同期减少了41.51%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800001398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0236","SG9999001069.SGD","BK0042","603882","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411001","title":"每周股票复盘：金域医学（603882）已回购217.51万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411001","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411001?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:12","pubTimestamp":1778350335,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，金域医学报收于28.13元，较上周的27.3元上涨3.04%。本周，金域医学5月8日盘中最高价报28.88元。本周关注点公司公告汇总：金域医学已累计回购217.51万股，占总股本的0.4695%。截至2026年4月30日，公司已累计回购股份217.51万股，占总股本的0.4695%，实际回购价格区间为26.22元/股至28.79元/股，已支付金额5,977.00万元。本次回购符合相关规定和方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0042","SG9999001069.SGD","BK0284","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634466207","title":"金域医学新注册《医学实验室质量管理智慧评估系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2634466207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634466207?lang=zh_cn&edition=full","pubTime":"2026-05-09 02:04","pubTimestamp":1778263460,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《医学实验室质量管理智慧评估系统V1.0》项目的软件著作权。今年以来金域医学新注册软件著作权27个，较去年同期减少了49.06%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息221条，著作权信息192条；此外企业还拥有行政许可58个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050900000223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","603882","BK0236","159180","BK0284","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633640185","title":"金域医学（603882）披露关于新增回购专用证券账户的公告，5月6日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633640185","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633640185?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:49","pubTimestamp":1778060986,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，金域医学报收于27.49元，较前一交易日上涨0.7%，最新总市值为127.35亿元。该股当日开盘27.52元，最高27.95元，最低27.35元，成交额达1.8亿元，换手率为1.42%。近日，广州金域医学检验集团股份有限公司发布《关于新增回购专用证券账户的公告》。回购期限为董事会审议通过之日起6个月内。公司已收到中国工商银行广州粤秀支行出具的融资承诺函，同意提供不超过18,000万元贷款用于回购股份，并已完成回购专用证券账户开立。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600028193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","603882","BK0236","BK0042","BK0284","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631268515","title":"金域医学（603882）披露调整2026年回购股份方案资金来源公告，4月29日股价上涨0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631268515","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631268515?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:48","pubTimestamp":1777463302,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，金域医学报收于27.52元，较前一交易日上涨0.77%，最新总市值为127.49亿元。该股当日开盘27.09元，最高27.77元，最低27.03元，成交额达1.35亿元，换手率为1.07%。广州金域医学检验集团股份有限公司于2026年4月29日发布公告，宣布将2026年回购股份方案的资金来源由“自有资金”调整为“自有资金和自筹资金”，回购总额仍为1.5亿元至2亿元，价格不超过35.00元/股，期限为董事会审议通过之日起6个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0236","603882","BK0042","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630975807","title":"金域医学（603882）2026年一季报简析：净利润同比增长254%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2630975807","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630975807?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:14","pubTimestamp":1777155290,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金域医学发布2026年一季报。截至本报告期末，公司营业总收入13.51亿元，同比下降7.88%，归母净利润4279.05万元，同比上升254.0%。本报告期金域医学盈利能力上升，毛利率同比增幅4.96%，净利率同比增幅249.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600003073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630802396","title":"每周股票复盘：金域医学（603882）2026年Q1净利增254%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630802396","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630802396?lang=zh_cn&edition=full","pubTime":"2026-04-26 04:41","pubTimestamp":1777149669,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，金域医学报收于28.28元，较上周的27.22元上涨3.89%。股本股东变化股东户数变动截至2026年3月31日，金域医学股东户数为4.31万户，较2025年12月31日增加3077户，增幅7.68%。广州金域医学检验集团股份有限公司2026年第一季度报告2026年第一季度公司实现营业收入1,350,977,738.08元，同比下降7.88%；利润总额61,072,831.86元，同比增长263.67%；归母净利润42,790,549.78元，同比增长254.00%；扣非净利润51,838,135.77元，同比增长233.95%；基本每股收益0.09元，同比增长250.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0284","603882","BK0236","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629828930","title":"金域医学最新公告：第一季度净利润为4279.05万元同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2629828930","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629828930?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:40","pubTimestamp":1777041650,"startTime":"0","endTime":"0","summary":"金域医学(603882.SH)公告称，2026年第一季度实现营业收入13.51亿元，同比下降7.88%；归属于上市公司股东的净利润为4279.05万元，同比扭亏为盈。业绩变动主要系加强成本管控，毛利率提升及信用减值损失减少所致。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628751428","title":"每周股票复盘：金域医学（603882）拟回购股份，梁耀铭持股16.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628751428","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628751428?lang=zh_cn&edition=full","pubTime":"2026-04-19 04:13","pubTimestamp":1776543186,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，金域医学报收于27.22元，较上周的26.61元上涨2.29%。本周，金域医学4月16日盘中最高价报27.93元。4月13日盘中最低价报26.21元。本周关注点公司公告汇总：金域医学拟以集中竞价交易方式回购股份。董事会公告回购股份决议前一交易日登记在册的前十大股东及前十大无限售条件股东持股情况已披露。股本股东变化截至2026年4月10日，公司总股本为463,258,275股，无限售条件流通股为460,134,577股。股东梁耀铭持股74,191,907股，占总股本16.02%，为第一大股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0284","603882","SG9999001069.SGD","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627426315","title":"金域医学新注册《知识产权数据智能提取发送工具系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2627426315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627426315?lang=zh_cn&edition=full","pubTime":"2026-04-15 02:06","pubTimestamp":1776189978,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《知识产权数据智能提取发送工具系统V1.0》项目的软件著作权。今年以来金域医学新注册软件著作权26个，较去年同期减少了48%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目27次；财产线索方面有商标信息766条，专利信息220条，著作权信息191条；此外企业还拥有行政许可58个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500002986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0236","159180","BK0042","603882","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621819500","title":"股市必读：金域医学（603882）3月23日收盘跌6.83%，主力净流入340.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621819500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621819500?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:54","pubTimestamp":1774295650,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，金域医学报收于24.98元，下跌6.83%，换手率1.85%，成交量8.51万手，成交额2.17亿元。来自交易信息汇总：3月23日主力资金净流入340.59万元，占总成交额1.57%。交易信息汇总股价提醒3月23日金域医学收盘报24.98元，跌6.83%，当日成交850.87万元。该股已连续3日下跌。前10个交易日中，主力资金累计净流出3830.55万元，股价累计下跌10.6.69%；融资余额累计减少766.08万元，融券余量累计增加300股。最近90天内，共有4家机构对该股给出买入评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0236","603882","SG9999001069.SGD","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621104085","title":"金域医学新注册《医学实验室生物安全智慧系统V3.2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2621104085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621104085?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:05","pubTimestamp":1774289120,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《医学实验室生物安全智慧系统V3.2.0》项目的软件著作权。今年以来金域医学新注册软件著作权25个，较去年同期减少了44.44%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.61亿元，同比减18.32%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息213条，著作权信息190条；此外企业还拥有行政许可57个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0284","BK0236","SG9999001069.SGD","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621962157","title":"金域医学新注册《金域tNGS宏组学plus加做管理系统V1.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2621962157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621962157?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:15","pubTimestamp":1774116916,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了3个项目的软件著作权，包括《金域tNGS宏组学plus加做管理系统V1.0》、《医学实验室智慧安全数据表系统V3.2.0》、《独立医学实验室经营决策实战培训系统V7.5.2》等。今年以来金域医学新注册软件著作权24个，较去年同期减少了35.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","SG9999001069.SGD","BK0236","BK0284","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620493482","title":"金域医学新注册《医检项目智慧定价系统（SPP）V2.38》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2620493482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620493482?lang=zh_cn&edition=full","pubTime":"2026-03-17 02:13","pubTimestamp":1773684793,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《医检项目智慧定价系统V2.38》项目的软件著作权。今年以来金域医学新注册软件著作权21个，较去年同期减少了40%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.61亿元，同比减18.32%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目29次；财产线索方面有商标信息766条，专利信息220条，著作权信息189条；此外企业还拥有行政许可57个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700001821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","SG9999001069.SGD","603882","BK0042","BK0236"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781237180372,"stockEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.1326},{"period":"3month","weight":-0.1562},{"period":"6month","weight":-0.1331},{"period":"1year","weight":-0.1812},{"period":"ytd","weight":-0.1463}],"compareEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":-0.054},{"period":"3month","weight":-0.0265},{"period":"6month","weight":0.0251},{"period":"1year","weight":0.1719},{"period":"ytd","weight":0.0046}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州金域医学检验集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"43126人(较上一季度增加7.68%)","perCapita":"10669股","listingDate":"2017-09-08","address":"广东省广州市海珠区国际生物岛螺旋三路10号","registeredCapital":"46325万元","survey":" 广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学诊断服务、销售诊断产品、健康体检业务、冷链物流服务。公司参与获批国家科技重大专项4项，国家“战略性科技创新合作”重点专项1项。全年发表论文共101篇，其中SCI论文32篇，学术影响力持续提升。","listedPrice":6.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金域医学,603882,金域医学股票,金域医学股票老虎,金域医学股票老虎国际,金域医学行情,金域医学股票行情,金域医学股价,金域医学股市,金域医学股票价格,金域医学股票交易,金域医学股票购买,金域医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}